CCL22 and breast ductal adenocarcinoma: There was only 1 fold change in CCL22 expression in ductal carcinoma observed in Curtis dataset (p = 2.34e−09)23, while Radvanyi conveyed a 1.9 greater fold change (p = 0.035) in lobular BrCa for CCL2225.